-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III

Symposia: Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Suganti Shivaram, M.B.B.S1*, Huihuang Yan, PhD2*, Hongwei Tang, PhD1*, Hans M. Anderson3*, Marcella Kaddoura, M.D.4*, J Erin Wiedmeier-Nutor, MD, MPH5, Shulan Tian, PhD2*, Michael D Howe6*, Abiola Bolarinwa, MBBS, FMCPath7*, Cinthya Zepeda Mendoza, PhD8*, Vikas A Gupta, MD, PhD9*, Stacey Lehman1*, Constantine S Mitsiades, MD10, P. Leif Bergsagel, MD11, Esteban Braggio, PhD12, Lawrence H. Boise, PhD13, Rafael Fonseca, MD14, Francesco Maura, MD15, Shaji Kumar, MD16 and Linda B. Baughn, PhD1

1Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
2Division of Computational Biology, Mayo Clinic, Rochester, MN
3Chemistry Department, Carleton College, Northfield, MN
4Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
5Division of Hematology, Mayo Clinic, Phoenix, AZ
6Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
7Mayo Clinic, Rochester, MN
8Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester
9Winship Cancer Institute, Emory University, Atlanta, GA
10Ludwig Center, Harvard Medical School, Brookline, MA
11Mayo Clinic Arizona, Phoenix, AZ
12Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ
13Emory University, Atlanta, GA
14Division of Hematology, Mayo Clinic, Paradise Valley, AZ
15University of Miami, Coral Gables, FL
16Division of Hematology, Mayo Clinic, Rochester, MN

Jason I. Avigan, MD*, Dylan C Gagler*, Hussein Ghamlouch, PhD*, Patrick Blaney, MS*, Di Zhang, MS*, Faith E Davies, MD and Gareth Morgan, M.D., Ph.D.*

Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Langone Health, New York, NY

Junko Tsuji, PhD1*, Elizabeth D. Lightbody, PhD1,2, Romanos Sklavenitis-Pistofidis, MD1,2, Ting Wu, MS1*, Michael P. Agius, PhD3*, Danielle T. Firer, BS1*, Mahshid Rahmat, PhD2*, Hadley Barr, BSc2*, Yoshinobu Konishi, MD, PhD1,4, Ankit K. Dutta, PhD2*, Jean-Baptiste Alberge, PhD1,2, Nang Kham Su, MSc2*, Cody J. Boehner, BSc2*, Michelle P. Aranha, PhD1,2*, Laura Hevenor2*, Katherine Towle2*, Erica M. Horowitz, BA2*, Maya Davis, BA2*, Jacqueline F Perry2*, Francois Aguet, PhD5*, Ruitong Li, MS1*, Sungjae Kim, PhD1*, Nicholas J. Haradhvala, PhD1*, Rebecca Boiarsky, MS6*, Gad Getz, PhD1,7,8* and Irene Ghobrial, MD2,7

1Broad Institute of MIT and Harvard, Cambridge, MA
2Dana-Farber Cancer Institute, Boston, MA
3Dana Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Brookline, MA
5Illumina, San Francisco, CA
6Massachusetts Institute of Technology, Cambridge, MA
7Harvard Medical School, Boston, MA
8Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA

Toru Ebina, MD1,2*, Masaki Ri, MD, PhD3*, Yoshiko Oshima, MD3*, Tomoyuki Nakamura4*, Yoshiaki Marumo, MD4*, Hirokazu Sasaki, MD3*, Arisa Asano, MD, PhD3*, Shiori Kinoshita, MD, PhD3*, Tomotaka Suzuki3*, Tomoko Narita, MD, PhD3*, Ayako Masaki, MD.PhD5*, Takaomi Sanda, MD, PhD3, Hirokazu Komatsu, MD, PhD3*, Hirotake Sakuraba, MD, PhD2* and Shinsuke Iida, MD, PhD6

1Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Aomori, Japan
2Department of Gastroenterology, Hematology and Clinical immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
3Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
4Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, AIC, Japan
5Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
6Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan

Jennifer Wing Lam Cheung, MSc1,2*, Prachurjya Panda3*, Xiang Zhou, MD, BMBS4,5, Katrin Sinning3*, Ankit Agrawal3*, Andy Shing Fung Chan3*, Johannes Duell, MD6,7,8*, Johannes Waldschmidt, MD5, Hermann Einsele, MD5,7,9,10,11,12, Martin Väth3*, Andreas Rosenwald, MD13*, Dominic Grün14,15* and Leo Rasche, MD16,17,18,19,20*

1Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius‐Maximilians-Universität Würzburg, Würzburg, AL, Germany
2Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
3Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius‐Maximilians-Universität Würzburg, Würzburg, Germany
4University Hospital Wuerzburg, Wurzburg, Germany
5Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
6Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wurzburg, Germany
7Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
8University of Wurzburg, Wurzburg, Germany
9University Hospital of Würzburg, Wurzburg, Germany
10Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, Würzburg, DEU
11Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
12Division of Medicine II, University Hospital Würzburg, Würzburg, Germany
13Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
14Würzburg Institute of Systems Immunology, Würzburg, Germany
15CAIDAS - Center for Artificial Intelligence and Data Science, Würzburg, Germany
16Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany
17Mildred Scheel Early Career Center for Cancer Research, University Hospital Wuerzburg, Wuerzburg, Germany
18University Hospital of Würzburg, Würzburg, Germany
19Wurzburg University, Würzburg, Germany
20Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Wei Tan1*, Minghao Dang, PhD1*, Upasana Ray1*, Luz Yurany Moreno Rueda, PhD, MSc1*, Maria Jose Acevedo-Calado, PhD1*, Hua Wang, PhD1*, Jun Wei1*, Li Qin, PhD1*, Isere Kuiatse, PhD1* and Robert Z. Orlowski, MD, PhD1,2

1Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX

Jonathan S. Wall, PhD*, Stephen J. Kennel, PhD*, Alan Stuckey, CNMT*, Tina Richey, MS*, Angela D. Williams, MS*, Manasi Balachandran, PhD*, Trevor Hancock, PhD*, Joseph W. Jackson, PhD*, D. Craig Wooliver*, Sallie Macy*, R. Eric Heidel, PhD*, Ronald H. Lands, MD and Emily B Martin, PhD*

University of Tennessee Health Science Center College of Medicine, Knoxville, TN

Noémie Leblay, PhD1*, Sungwoo Ahn, PhD1*, Holly Lee, MD1, Matteo Claudio Da Vià, MD2*, Mansour Poorebrahim, PhD1*, Sacha Benaoudia, PhD1*, David Jung, BSc1*, Elham Hasheminasabgorji, MSc1*, Niccolò Bolli, MD, PhD2*, Nizar J. Bahlis, MD1 and Paola Neri, MD, PhD1

1Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

Li Zhou, MD1,2*, Xiaotong Song3* and Zhimin Zhai, MD1,2

1Department of Hematology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China
2Anhui Medical University, Hefei, China
3Icell Keleax Therapeutics, Houston, TX

Enze Liu, PhD1*, Nathan Becker, MS2*, Parvathi Sudha, MS1*, Aneta Mikulasova, PhD3*, Rafat Abonour, MD1 and Brian A. Walker, PhD1,4

1Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN
2Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Fishers, IN
3Centre for Cancer and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom
4Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN

Praneeth Reddy Sudalagunta, PhD1*, David R. Noyes, MS2*, Gabriel De Avila3*, Alexandra Achille2*, Rafael Renatino-Canevarolo, PhD1*, Xiaohong Zhao, MD, PhD2*, Maria Silva1*, Angel Perez1*, Mark B. Meads, PhD4*, Lauren C. Peres, PhD, MPH5*, Doris K. Hansen, MD6*, Kenneth H. Shain, MD, PhD4 and Ariosto Siqueira Silva, PhD7*

1Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4H. Lee Moffitt Cancer Center, Tampa, FL
5Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
6Moffitt Cancer Center, Tampa, FL
7Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Bonell Patiño-Escobar, MD1*, Lucy Perez-Lugo, MD1,2*, Huimin Geng, PhD1*, Fernando Salangsang3*, Paul Phojanakong, BA3*, Juan Antonio Camara Serrano, PhD3*, Veronica Steri, PhD3*, Oscar A Aguilar, PhD4* and Arun P Wiita, MD, PhD5

1Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
2Department of Hematology-Oncology, Fundación Valle de Lili, Cali, Colombia
3Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
4Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA
5Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

Yifan Hou1*, Jianwei Qu1*, Enfan Zhang2* and Zhen Cai2*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Ankita Srivastava, M.Tech1*, Romika Kumari, PhD2*, Juho J. Miettinen, PhD2*, Minna H. Suvela2*, Klara Acs, PhD3*, Sini Luoma, MD4* and Caroline A. Heckman, PhD1

1Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
2Institute for Molecular Medicine Finland – FIMM, HiLIFE – Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
3Oncopeptides AB, Stockholm, Sweden
4Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Ya-Wei Qiang1,2*, Michelle Karam, BS1*, Allyson Schimelman, BS1,3*, Edward Jachimowicz, MS1*, Heather Fairfield, MS1,2* and Michaela R Reagan, PhD2,4

1Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME
2Tufts University School of Medicine, Boston, MA
3The Roux Institute at Northeastern University, Portland, ME
4Center for Molecular Medicine, MaineHealth Institute for Research, South Portland, ME

Vinidhra Sridharan1*, Hsiling Chiu1*, Shirong Li1*, Chad C. Bjorklund1*, Anita K. Gandhi, PhD2 and Patrick R. Hagner, PhD1*

1Bristol Myers Squibb, Summit, NJ
2Hematology, Translational Medicine, Bristol Myers Squibb, Summit, NJ

Holly Lee, MD1, David Jung, BSc1*, Mansour Poorebrahim, PhD1*, Sacha Benaoudia, PhD1*, Sungwoo Ahn, PhD1*, Noémie Leblay, PhD1*, Eric Letouzé, PhD2*, Philippe Moreau, MD, PhD3*, Herve Avet-Loiseau, MD, PhD4*, Leo Rasche, MD5*, Jonathan J Keats, PhD6, Francesco Maura, MD7, Paola Neri, MD, PhD1 and Nizar J. Bahlis, MD1

1Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
2Nantes Université, Nantes, FRA
3Department of Hematology, Nantes University Hospital, Nantes, France
4Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France
5Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany
6Translational Genomics Research Institute, Phoenix, AZ
7University of Miami, Coral Gables, FL

Alice Cleynen, PhD1*, Agin Ravindran2*, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS3, Eduardo Eyras, PhD2* and Nikolay Shirokikh, PhD4*

1Universite De Montpellier, Montpellier, France
2The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia
3College of Health and Medicine, Australian National University, Red Hill, Australia
4ANU, John Curtin School of Public Health, Canberra, Australia

Diana Cortes, PhD1*, Brendan Paul Hodkinson, PhD, BS1*, Ashwini Kumar, PhD1, Sheri Skerget, PhD1*, Gary E Mason, MD, MS1*, Elizabeth Shearin, PharmD2*, Hein Ludlage, MSc2*, Bas D Koster, MD, PhD3, Colleen Kane, PhD1, Thomas Renaud, MD4, Tobias Kampfenkel, MD, MHBA5*, Christoph Heuck, MD1*, Bhoomika Thakkar, MS4*, Farheen Zishan6*, Emma Searle, MD, PhD7*, Hang Quach, MD, FRACP, FRCPA, MBBS8, Gayathri Ravi, MD9, Cyrille Hulin, MD10*, Wojciech Janowski, MD11*, Jesus G Berdeja, MD12, Sébastien Anguille, MD13*, Jeffrey V Matous, MD14, Cyrille Touzeau, MD, PhD15*, Anne-Sophie Michallet, MD, PhD16*, Ajay K. Nooka, MD, MPH17, Tara Cochrane, MBBS, FRCPA, FRACP18, Anita D'Souza, MD, MS19*, Peter M. Voorhees, MD20, Karthik Ramasamy, MBBS, PhD21*, Aurore Perrot, MD, PhD22, Andrew Spencer, MBBS23*, Gurdeep Parmar, MBBS24* and Deeksha Vishwamitra1

1Janssen Research & Development, Spring House, PA
2Janssen-Cilag Benelux, Leiden, Netherlands
3Janssen Biologics Europe, Leiden, Netherlands
4Janssen Research & Development, Raritan, NJ
5Janssen Research & Development, Neuss, Germany
6Janssen Research & Development, High Wycombe, United Kingdom
7The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
8University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
9University of Alabama at Birmingham, Birmingham, AL
10Hôpital Haut Leveque, University Hospital, Pessac, France
11Calvary Mater Newcastle, Waratah, NSW, Australia
12Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN
13Vaccine and Infectious Disease Institute, University of Antwerp, Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium
14Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
15Centre Hospitalier Universitaire de Nantes, Nantes, France
16Hospices Civils, Centre Hospitalier Lyon Sud, Pierre Bénite, France
17Winship Cancer Institute, Emory University, Atlanta, GA
18Gold Coast University Hospital and Griffith University, Gold Coast, QLD, Australia
19Medical College of Wisconsin, Milwaukee, WI
20Atrium Health Levine Cancer Institute, Charlotte, NC
21Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom
22Centre Hospitalier Universitaire de Toulouse, Oncopole, Toulouse, France
23School of Translational Medicine, Alfred Health-Monash University, Melbourne, VIC, Australia
24lllawarra Cancer Care Centre, Wollongong, NSW, Australia

Junia Vieira, MD, PhD1*, Alison S Park, BSc2*, David Melnekoff, PhD1*, Tarek H. Mouhieddine, MD3, Alessia D'anna, PhD2*, Adolfo Aleman, Jr.4*, Meghana Ram, BSc5*, Katerina Kappes, BSc4*, Mark Hamilton, MD6, George Mulligan, PhD6, Arun P Wiita, MD, PhD7, Ajai Chari, MD8, Thomas Martin, MD9, Michael Slade, MD, MS10, Li Ding, PhD11*, Ravi Vij, MD, MBA12, Brian Brown, PhD5*, Benjamin Tycko, MD, PhD13*, Rena Feinman, PhD14, David S. Siegel, MD, PhD15, Sundar Jagannath, MD1, Samir Parekh, MD1 and Alessandro Lagana, PhD16

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Icahn School of Medicine at Mount Sinai, New York
3Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
4Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
5Icahn School of Medicine at Mount Sinai, New York, NY
6Multiple Myeloma Research Foundation, Norwalk, CT
7Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
8University of California, San Francisco, San Francisco, CA
9Department of Hematology, University of California at San Francisco, San Francisco, CA
10Division of Oncology, Washington University School of Medicine, Saint Louis, MO
11Washington University, St. Louis, MO
12Division of Oncology, Washington University School of Medicine, St. Louis, MO
13Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ
14Center for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ
15Hackensack University Medical Center, Hackensack, NJ
16Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

Patrick Blaney, MS1,2*, Kylee H Maclachlan, PhD, BSc, FRACP, FRCPA3, Marios Papadimitriou, MD4*, Aneta Mikulasova, PhD5*, Dylan C Gagler1,2*, Marc J Braunstein, MD, PhD1, Oscar B Lahoud, MD1, David Kaminetzky, MD1*, Yubao Wang, PhD1*, Sanxiong Liu, PhD1*, Di Zhang, MS1*, Anthony Cirrincione, PhD4*, Alexandra Maria Poos, PhD6*, Bachisio Ziccheddu4*, Marcella Kaddoura, MD7, Monika Chojnacka, B.S.4, Benjamin Diamond, MD4, Neha Korde, MD3, Alexander M. Lesokhin, MD3, Saad Z. Usmani, MD3, Leo Rasche, MD8*, Elias K. Mai, MD6*, Marc S. Raab6*, Niels Weinhold, PhD6, Elizabeth E. Brown, PhD, MPH9, Nicolas Robine, PhD10*, Leif Bergsagel, MD11, Brian A. Walker, PhD12, Ola Landgren4, Francesco Maura, MD13, Faith E Davies, MD1 and Gareth Morgan, M.D., Ph.D.1*

1Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Langone Health, New York, NY
2Applied Bioinformatics Laboratories, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
3Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
5Centre for Cancer and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom
6Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
7Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Dearborn, MI
8Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany
9Department of Pathology, University of Alabama At Birmingham, Birmingham, AL
10New York Genome Center, New York, NY
11Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
12Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN
13University of Miami, Coral Gables, FL

Mattia Dessena, PhD1*, Tommaso Torelli, MSc2*, Cristina Manferdini, MSc3*, Denise Toscani, PhD1*, Alessandro Guidi, MSc2*, Rosanna Vescovini, PhD1*, Nicolas Thomas Iannozzi, MSc1*, Anna Benedetta Dalla Palma, MD, PhD4*, Vincenzo Raimondi1*, Oxana Lungu, MSc1*, Federica Librale, MD4*, Matia Bernardi, MD4*, Stefania Ricci, MSc1*, Laura Pelagatti, MD4*, Giannalisa Todaro, PhD4*, Gabriella Sammarelli, PhD4*, Camilla Sitzia, MSc1*, Emanuela Aleo5*, Gina Lisignoli, MSc3*, Luca Agnelli, PhD2*, Nicola Giuliani, MD, PhD1,4 and Paola Storti, PhD1*

1Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy
2Department of Advanced Diagnostic Innovations, IRCCS Istituto Nazionale Tumori, Milano, Italy
3Laboratory of Immunorheumatology and tissue regeneration, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
4Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
5IGA Technology Services, Udine, Italy

Travis Johnson, PhD1, Enze Liu, PhD2*, Ke Yang3*, Parvathi Sudha, MS2*, Vivek S. Chopra4*, Faiza Zafar4*, Rafat Abonour, MD2 and Brian A. Walker, PhD2

1Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN
2Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN
3IU Health, Indianapolis
4Genentech, Inc., South San Francisco, CA

Junia Vieira, MD, PhD1*, Alison S Park, BSc2*, Edgar Gonzalez-Kozlova, PhD3*, David Melnekoff, PhD1*, Sherry Bhalla, PhD4*, Chaitanya Acharya, PhD5*, Mark Hamilton, MD6, George Mulligan, PhD6, Immune Atlas Network7*, Hearn Jay Cho, MD, PhD8, Li Ding, PhD9*, Sacha Gnjatic, PhD10*, Ioannis S Vlachos, PhD11*, Manoj Bhasin, PhD12, Sundar Jagannath13, Samir Parekh, MD1 and Alessandro Lagana, PhD14

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Icahn School of Medicine at Mount Sinai, New York
3MSSM, New York
4Mount Sinai Hospital, New York, NY
5MMRF, Norwalk, CT
6Multiple Myeloma Research Foundation, Norwalk, CT
7MMRF, Norwalk
8Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Tisch Cancer Institute, New York, NY
9WUSTL, St Louis
10Icahn School of Medicine at Mount Sinai, New York, NY
11Beth Israel Deaconess Medical Center, Boston, MA
12Department of Biomedical Engineering, Georgia Institute of Technology, Johns Creek, GA
13Mount Sinai Medical Center, New York, NY
14Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

Qun Li1*, Chi Ma2*, Liping Zuo2*, Aoshuang Xu2*, Fei Zhao2*, Yu Hu2* and Chunyan Sun2*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong Univer, Wuhan, China
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Vincenzo Raimondi, MSc1*, Paola Storti, PhD1*, Rosanna Vescovini, PhD1*, Valentina Franceschi, PhD2*, Giulia Pozzi, PhD3*, Denise Toscani, PhD1*, Nicolas Thomas Iannozzi, MSc1*, Oxana Lungu, MSc1*, Anna Benedetta Dalla Palma, MD, PhD4*, Laura Pelagatti, MD4*, Federica Librale, MD4*, Mattia Dessena, PhD1*, Stefania Ricci, MSc1*, Prisco Mirandola, PhD3*, Gaetano Donofrio, VMD, PhD2* and Nicola Giuliani, MD, PhD1,4

1Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy
2Department of Medical-Veterinary Science, University of Parma, Parma, Italy
3Department of Medicine and Surgery, University of Parma, Parma, Italy
4Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

Zijun Zhang1*, Yan Cheng2*, David E. Mery, PhD2, Hongwei Xu, DDS2*, Brian Koss3*, Behjatolah Monzavi Karbassi4*, John D Shaughnessy, Jr, PhD2* and Fenghuang Zhan, MD2

1Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical, Little Rock, AR
2Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
3University of Arkansas For Medical Sciences,, Little Rock, AR
4Department of Pathology, University of Arkansas for Medical, Little Rock, AR

Shijun Jiang1*, Fengjuan Fan2*, Klaus Podar, MD, PhD3,4, Chunyan Sun, MD1* and Yu Hu1*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Union Hospital, Tongji Medical College, Huazhong University of Science and Techn, Wuhan, China
3Division of Molecular Oncology and Hematology, Department of Basic and Translational Oncology, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
4Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria

Shannon M Matulis, PhD1*, Robert M Chavez2*, Rebecca Owens, B.S.3*, Arun P Wiita, MD, PhD4, Mala Shanmugam5, Ricardo De Matos Simoes, PhD6*, Constantine S Mitsiades, MD7,8, Nisha S. Joseph, MD9, Craig C. Hofmeister, MD10, Jonathan L. Kaufman, MD10, Madhav V. Dhodapkar, MD PhD10, Sagar Lonial, MD11*, Ajay K. Nooka, MD, MPH12, Vikas A. Gupta, MD PhD9, Jonathan D. Licht, MD13, Benjamin G. Barwick, PhD14 and Lawrence H. Boise, PhD15

1Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA
2Emory University, Atlanta, GA
3Winship Cancer Institute, Emory Univeristy School of Medicine, Atlanta, GA
4Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
5Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Ludwig Center, Harvard Medical School, Brookline, MA
8Dana-Farber Cancer Institute, Boston, MA
9Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
10Winship Cancer Institute of Emory University, Atlanta, GA
11Winship Cancer Institute, Atlanta, GA
12Winship Cancer Institute of Emory University, Atlanta
13University of Florida, Gainesville, FL
14Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA
15Department of Hematology and Medical Oncology, Winship Cancer Institute, Winship Cancer Institute, Atlanta, GA

Raquel Lopes1,2*, Ana C Queirós, PhD1*, Diana Lourenço1*, Rita C Acúrcio3,4*, Bjarne Bogen, MD, PhD5*, Karine Serre, PhD6*, Helena F Florindo, PhD3,4* and Cristina João, MD, PhD, MSc1,7,8*

1Myeloma Lymphoma Research Group, Champalimaud Foundation, Lisbon, Portugal
2Faculty of Medicine, University of Lisbon, Lisbon, Portugal
3Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
4Research Institute for Medicines, Lisbon, Portugal
5Institute of Immunology, University of Oslo, Oslo, Portugal
6Instituto De Medicina Molecular, Lisboa, Portugal
7Hemato-Oncology Unit, Champalimaud Foundation, Lisbon, Portugal
8NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal

Paula Tabares1*, Antonio Giovanni Solimando2*, Jayabhuvaneshwari Dhanraj3*, Lukas Scheller, MD4*, Matteo DA VIA, MD5*, Alexis Gonzalez-Diaz6*, Sanisha Sunuwar, MSc7*, Katharina Schmiedgen8*, Hüsniye Dagdeviren9*, Mateo Blazevic6*, Vanessa Desantis, PhD10*, Francesca Lazzaroni, PhD11*, Robin Scheler-Eckstein6*, Martin K. Kortüm12*, Leo Rasche, MD13*, Johannes Waldschmidt, MD14, Max Bittrich, MD15*, Stefan Knop16*, Hermann Einsele, MD15 and Andreas Beilhack15*

1University Hospital of Würzburg, Würzburg, Germany
2Medicina interna universitaria Guido Baccelli, Ospedale Policlinico di Bari, Bari, Italy
3Interdisciplinary Center for Clinical Research Laboratory, Würzburg University Hospital, Würzburg, Germany., 97078 Würzburg, Germany
4Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
5Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
6Department of Medicine II, Würzburg University Hospital II, Germany., Würzburg, Germany
7Department of Medicine II, Würzburg University Hospital II, Germany., Würzburg, DEU
8Interdisciplinary Center for Clinical Research Laboratory, Würzburg University Hospital, Würzburg, Germany., Würzburg, DEU
9Interdisciplinary Center for Clinical Research Laboratory, Würzburg University Hospital, Würzburg, Germany., Würzburg, Germany
10Department of Biomedical Sciences and Human Oncology (DIMO), Pharmacology Section, University of Bari Medical School, Bari, AL, ITA
11Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, Milano, Italy
12Würzburg University Hospital, Wuerzburg, Germany
13Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany
14Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
15Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
16Department of Internal Medicine 5, Paracelsus Medical School, Nuremberg General Hospital, Nürnberg, DEU

Christopher Rolf Schorr1,2, Daniela Nicoleta Petrusca, PhD2, Louise Carlson2*, Joyce Hardwick2*, Julia Grace Reinke2* and Kelvin P. Lee, MD3

1Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN
2Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN
3Melvin and Bren Simon Comprehensive Cancer Center, INDIANA UNIVERSITY, INDIANAPOLIS, IN

Ceanne Elliott, BS1*, Enze Liu, PhD1*, Nathan Becker, MS2*, Parvathi Sudha, MS1*, Oumaima Jaouadi, PhD1* and Brian A. Walker, PhD1,3

1Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN
2Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Fishers, IN
3Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN

Teng Fang, PhD1*, Lanting Liu2*, Hao Sun2*, ?? ?1*, Xiyue Sun2*, Zhen Yu2*, Lugui Qiu1 and Mu Hao, MD2*

1State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

*signifies non-member of ASH